Increased and mistimed sex hormone production in night shift workers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Kyriaki PapantoniouManolis Kogevinas

Abstract

Night shift work has been associated with an increased risk for breast and prostate cancer. The effect of circadian disruption on sex steroid production is a possible underlying mechanism, underinvestigated in humans. We have assessed daily rhythms of sex hormones and melatonin in night and day shift workers of both sexes. We recruited 75 night and 42 day workers, ages 22 to 64 years, in different working settings. Participants collected urine samples from all voids over 24 hours on a working day. Urinary concentrations of 16 sex steroid hormones and metabolites (estrogens, progestagens, and androgens) and 6-sulfatoxymelatonin were measured in all samples. Mean levels and peak time of total and individual metabolite production were compared between night and day workers. Night workers had higher levels of total progestagens [geometric mean ratio (GMR) 1.65; 95% confidence intervals (CI), 1.17-2.32] and androgens (GMR: 1.44; 95% CI, 1.03-2.00), compared with day workers, after adjusting for potential confounders. The increased sex hormone levels among night shift workers were not related to the observed suppression of 6-sulfatoxymelatonin. Peak time of androgens was significantly later among night workers, compared with day work...Continue Reading

References

May 1, 1988·Annals of Clinical Biochemistry·M E Aldhous, J Arendt
Apr 1, 1987·American Journal of Epidemiology·R G Stevens
Aug 1, 1996·European Journal of Endocrinology·O VakkuriA Kauppila
Sep 7, 2001·Environmental Health Perspectives·R C Gwynn, G D Thurston
Oct 1, 2003·Statistics in Medicine·Susan K MikulichThomas J Crowley
Feb 3, 2005·Journal of Pineal Research·Samuel CosEmilio J Sánchez-Barceló
May 26, 2005·The Journal of Clinical Endocrinology and Metabolism·John AxelssonUlf Holmbäck
Sep 13, 2005·Journal of Occupational and Environmental Medicine·James B BurchEmily Allen
Jan 31, 2006·Journal of Pineal Research·Eva S SchernhammerSusan E Hankinson
Jul 11, 2006·Annals of Clinical Biochemistry·Walid K JerjesNorman F Taylor
Aug 28, 2007·The Journal of Steroid Biochemistry and Molecular Biology·Susan E Hankinson, A Heather Eliassen
Nov 3, 2007·Cancer Research·Akila N ViswanathanEva S Schernhammer
Nov 15, 2007·Journal of Occupational and Environmental Medicine·Maggie L ClarkJohn S Reif
Jan 31, 2008·Journal of the National Cancer Institute·UNKNOWN Endogenous Hormones and Prostate Cancer Collaborative GroupTimothy J Key
Jun 19, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Chisato NagataHiroyuki Shimizu
Nov 18, 2008·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·P Van RenterghemF T Delbeke
Dec 17, 2008·Current Cancer Drug Targets·S CosE J Sánchez-Barceló
Apr 22, 2009·International Journal of Epidemiology·Richard G Stevens
Jan 7, 2010·Occupational Medicine·Josephine Arendt
Feb 4, 2010·Scandinavian Journal of Work, Environment & Health·Giovanni CostaRichard Stevens
May 13, 2010·Journal of Circadian Rhythms·Daniel F KripkeKatharine M Rex
Jul 5, 2011·Medical Hypotheses·L FritschiT C Erren
Aug 30, 2011·Molecular and Cellular Endocrinology·Takumi OtaHitoshi Okamura
Jan 11, 2012·Journal of the National Cancer Institute·Barbara J FuhrmanRegina G Ziegler
Jan 24, 2012·BMJ Open·Annie R LangleyKristan J Aronson
Feb 9, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Scott DavisFrank Z Stanczyk
Mar 1, 2012·Cancer Causes & Control : CCC·E S SchernhammerW Y Chen
May 9, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Lara G SigurdardottirLorelei A Mucci
Jan 4, 2013·Breast Cancer Research and Treatment·Xuehong ZhangSusan E Hankinson
Mar 2, 2013·Oncology Reports·Virginia Alvarez-GarcíaSamuel Cos
Jun 20, 2013·Breast Cancer Research : BCR·Eva S SchernhammerPaola Muti
Jun 28, 2013·Scandinavian Journal of Work, Environment & Health·Sharea IjazKaisa Neuvonen
Oct 22, 2013·Occupational and Environmental Medicine·Kyriaki Papantoniou, Manolis Kogevinas
Apr 18, 2014·Current Opinion in Endocrinology, Diabetes, and Obesity·Gary Wittert
May 9, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kyriaki PapantoniouManolis Kogevinas

❮ Previous
Next ❯

Citations

Oct 17, 2015·The Journal of Steroid Biochemistry and Molecular Biology·Lily Yan, Rae Silver
Mar 12, 2017·Nutrients·Brad AisbettSéverine Lamon
Jul 13, 2017·International Journal of Cancer. Journal International Du Cancer·Fangyi GuNeil E Caporaso
Mar 22, 2018·Bioanalysis·Jose Rodríguez-MoratóJosep Marcos
Aug 1, 2018·International Journal of Molecular Sciences·Stephen C Bondy, Arezoo Campbell
Mar 11, 2020·Chronobiology International·Qunyan XuJane Warland
Nov 6, 2018·International Journal of Endocrinology·Javier Menéndez-Menéndez, Carlos Martínez-Campa
Jun 26, 2020·Journal of Cancer Research and Clinical Oncology·Saptadip Samanta
Nov 6, 2015·Frontiers in Endocrinology·Valérie Simonneaux, Thibault Bahougne
May 2, 2019·The Journal of Clinical Endocrinology and Metabolism·Peter Y Liu
Jul 31, 2019·Journal of Cancer Prevention·Srmena Krstev, Anders Knutsson
Sep 26, 2020·International Journal of Cancer. Journal International Du Cancer·Jakob WeitzerManolis Kogevinas
Oct 13, 2020·Frontiers in Endocrinology·María García-CostelaJosefa León
Feb 5, 2021·Antioxidants·Maria-Angeles Bonmati-Carrion, Antonia Tomas-Loba
Feb 20, 2021·The Analyst·Eulalia OlestiSerge Rudaz
May 4, 2021·Current Opinion in Endocrine and Metabolic Research·Nora A O'ByrnePeter Y Liu
Aug 14, 2021·Journal of Hypertension·Elissa K HoopesMelissa A Witman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Chisato NagataHiroyuki Shimizu
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Scott DavisFrank Z Stanczyk
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Dana K MirickScott Davis
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Beata PeplonskaGiske Ursin
© 2022 Meta ULC. All rights reserved